IRVINE, Calif., May 21, 2017 -- Pain Management Center of Irvine recently released information on the superiority of SurForce® compared to prolotherapy or PRP. Unlike the alternatives, which take hours per appointment, SurForce® only requires 15 minutes per session. SurForce® is also painless, while the other two options can be painful. The SurForce® treatments also promote healing rather than only managing pain.
Prolotherapy is an older treatment method that involves injecting dextrose into painful tissues to intentionally cause an inflammatory response. The underlying belief is that it will cause the body to speed healing in the inflamed area as well as the injured part. In practice, however, it is used to manage pain instead of to regenerate tissue. Unfortunately, the inflammation it brings on actually causes pain for the duration of the treatments.
Platelet Rich Plasma (PRP) is a stem cell therapy made up of blood, bone marrow, and fat (adipose) tissue. Getting these ingredients involves sucking bone marrow and fat out of the patient's body, and this is said to be a very painful process. It is even worse for older patients since they have fewer viable stem cells and need to donate more tissue to make up for this.
"It is clear that these older methods each have significant shortcomings. This is why we decided to implement the SurForce® system instead. SurForce® combines amniotic membrane tissue, biological scaffolding, and hyaluronic acid to provide a strong healing boost to painful areas via the addition of stem cells. This not only relieves pain, but allows the body to heal faster. Even better, this treatment is delivered by a painless injection," explained Dr. Rick Letts of Pain Management Center of Irvine.
Many people have questions when they learn that amniotic membrane is part of the SurForce® treatment. Specifically, they want to know where it comes from. There is no need for concern over this aspect of SurForce®. The FDA regulated amniotic membrane is voluntarily donated by women who have had cesarean deliveries.
Like many other healing treatments, SurForce® takes several weeks to fully implant in a patient, which is when the most noticeable improvement to their condition can be observed. Therefore, patients are advised to stick to light activity for the first few weeks. This ensures that everything will heal properly and prevent further injury during the course of treatment.
About Pain Management Center of Irvine
The Center offers a wide variety of pain management treatments, ranging from advanced stem cell therapy all the way to traditional healing methods like acupuncture and cupping. It serves the area of Irvine, CA.
To learn more about SurForce®, visit the Pain Management Center of Irvine’s website at http://chirocenterofirvine.com/.
Pain Management Center of Irvine 4902 Irvine Center Dr. #201 Irvine, CA 92604 (949) 857-4712


First Abu Dhabi Bank Reports 22% Jump in Q4 Profit, Beats Market Expectations
Tesla Loses Ground in Europe as BYD Accelerates EV Market Share in 2025
Volkswagen CEO Oliver Blume Faces Crucial Year as Investors Demand Turnaround Results
Puma’s Historic Rivalry With Adidas Enters a New Era as Anta Deal Signals Turnaround Push
Woodside Energy Flags Lower 2026 Production Outlook Despite Strong Q4 Revenue Beat
ASML’s EUV Monopoly Powers the Global AI Chip Boom
SoftBank Shares Surge as It Eyes Up to $30 Billion New Investment in OpenAI
LVMH Investors Watch Earnings Closely as Luxury Recovery Faces New Challenges
NVIDIA, Microsoft, and Amazon Eye Massive OpenAI Investment Amid $100B Funding Push
BYD and Exxon Mobil Strengthen Hybrid Technology Partnership
Elon Musk Reportedly Eyes June 2026 SpaceX IPO Timed With Planetary Alignment and Birthday
The Maire - EuroChem Case: Three Lessons for Global Business
Tesla Q4 Earnings Beat Expectations as Company Accelerates Shift Toward AI and Robotics
Boeing Posts Fourth-Quarter Profit on Jeppesen Sale Despite Ongoing Unit Losses
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex
Google Disrupts Major Residential Proxy Network IPIDEA
C3.ai in Merger Talks With Automation Anywhere as AI Software Industry Sees Consolidation 



